Jubilant Ingrevia Limited (BOM:543271)

India flag India · Delayed Price · Currency is INR
641.70
-23.65 (-3.55%)
At close: Feb 13, 2026
Market Cap101.32B -2.7%
Revenue (ttm)42.61B +1.4%
Net Income2.66B +28.7%
EPS16.76 +28.4%
Shares Outn/a
PE Ratio38.16
Forward PE29.24
Dividend5.00 (0.75%)
Ex-Dividend DateFeb 10, 2026
Volume10,757
Average Volume16,851
Open665.20
Previous Close665.35
Day's Range637.20 - 665.20
52-Week Range556.55 - 851.85
Betan/a
RSI46.00
Earnings DateFeb 4, 2026

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition... [Read more]

Industry Chemicals and Allied Products
Founded 2019
Employees 2,139
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543271
Full Company Profile

Financial Performance

In fiscal year 2025, Jubilant Ingrevia's revenue was 41.78 billion, an increase of 1.01% compared to the previous year's 41.36 billion. Earnings were 2.51 billion, an increase of 37.34%.

Financial Statements